Analytical Data
-
基因名
SLC43A2
- Application
-
别名
(L-type amino acid transporter 4)(Solute carrier family 43 member 2)
-
种属
Human
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8N370
-
表达区间
224-322aa
-
分子量
15.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC43A2, also known as the solute carrier family 43 member 2, is a recently identified gene that plays a crucial role in the transport of certain amino acids, particularly in the context of cell metabolism and physiology. It has garnered attention in research due to its implications in various physiological processes, including neurotransmitter regulation, immune response, and cellular stress management. Additionally, studies have indicated that SLC43A2 may be associated with certain diseases, such as cancer and neurodegenerative disorders, where altered amino acid transport could contribute to pathological conditions. The recombinant protein of SLC43A2 is essential for elucidating its functional mechanisms in these processes. By generating and characterizing the SLC43A2 recombinant protein, researchers aim to investigate its transport activity, structural properties, and interaction with other biomolecules. This research could pave the way for understanding the molecular basis of diseases linked to amino acid transport dysregulation and may lead to the development of new therapeutic strategies targeting these pathways. Overall, the study of SLC43A2 recombinant protein holds significant promise for advancing our knowledge in cellular biology and addressing health-related challenges linked to this important transporter.
